Availability of Hepatitis B Vaccine That Does Not Contain Thimerosal as a Preservative
1999; American Medical Association; Volume: 282; Issue: 13 Linguagem: Inglês
10.1001/jama.282.13.1219
ISSN1538-3598
Tópico(s)Hepatitis B Virus Studies
ResumoOn August 27, 1999, Merck Vaccine Division (Merck & Co., Inc., West Point, Pennsylvania) received approval from the Food and Drug Administration (FDA) of a supplement to Merck's license application to include the manufacture of single-antigen preservative-free hepatitis B vaccine (Recombivax HB, Pediatric); distribution is expected to begin September 13, 1999. In addition, SmithKline Beecham Biologicals (SmithKline Beecham, Philadelphia, Pennsylvania), expects to make single-antigen preservative-free hepatitis B vaccine (Engerix-B, Pediatric) available in the near future. Further product information will be provided when it becomes available. Product packaging and labels will indicate that these vaccines do not contain preservative.
Referência(s)